Status:

COMPLETED

Assessment of Inflammatory and Functional Changes in the Ocular Surface Associated With Dry Eye Disease

Lead Sponsor:

University of Waterloo

Collaborating Sponsors:

Alcon Research

Conditions:

Sjogren's Syndrome

Dry Eye

Eligibility:

All Genders

17-70 years

Brief Summary

This project will examine the similarities and differences of the ocular surface and tear film in patients with Sjogren's syndrome related to dry eye, severe dry eye and those who do not have dry eye....

Detailed Description

Dry eye is a multifactorial disease of the tears and ocular surface that results in symptoms of discomfort, visual disturbance and tear film instability with potential damage to the ocular surface. It...

Eligibility Criteria

Inclusion

  • Inclusion criteria (Sjogren's group)
  • A person is eligible for inclusion in the study, for the dry eye group, if she:
  • Has been diagnosed to have SS(confirmed via American-European Consensus Criteria 2002)and dry eye and half of the time wants to use eye drops for dry eye symptoms (dry eye group).
  • Has read, understood and signed an information consent letter.
  • Is willing and able to follow instructions and maintain the appointment schedule.
  • Has had an ocular examination in the last two years.
  • Inclusion criteria (severe DE group)
  • A person is eligible for inclusion in the study, for the dry eye group, if he/she:
  • Has moderate or severe dry eye symptoms based on dry eye questionnaire and half of the time wants to use eye drops for dry eye symptoms (dry eye group)
  • Has read, understood and signed an information consent letter.
  • Is willing and able to follow instructions and maintain the appointment schedule.
  • Has had an ocular examination in the last two years.
  • Inclusion criteria (control group)
  • A person is eligible for inclusion in the study, for the control group, if he/she:
  • Has read, understood and signed an information consent letter.
  • Is willing and able to follow instructions and maintain the appointment schedule.
  • Has clear corneas and no active ocular disease.
  • Has had an ocular examination in the last two years.

Exclusion

  • A person will be excluded from the study if he/she (Sjogren's group):
  • Is a contact lens wearer.
  • Has any clinically significant belpharitis.
  • Has undergone corneal refractive surgery.
  • Is aphakic.
  • Has any active ocular disease.
  • Is using any systemic or topical medications that may affect ocular health.
  • Has known sensitivity to the diagnostic pharmaceuticals to be used in the study.
  • Is participating in any other type of clinical or research study.
  • A person will be excluded from the study if he/she (Dry eye group):
  • Is a contact lens wearer.
  • Has any clinically significant belpharitis.
  • Has undergone corneal refractive surgery.
  • Is aphakic.
  • Has any active ocular disease.
  • Is using any systemic or topical medications that may affect ocular health.
  • Has known sensitivity to the diagnostic pharmaceuticals to be used in the study.
  • Is participating in any other type of clinical or research study.
  • A person will be excluded from the study if he/she (control group):
  • Has rheumatoid arthritis, diabetes, Sjogren's syndrome or any other systemic disease affecting ocular health.
  • Is using any systemic or topical medications (other than eye drops for dry eye symptoms) that may affect ocular health and neuro-endocrine system function.
  • Has undergone corneal refractive surgery.
  • Is aphakic.
  • Has any active ocular disease.
  • Has known sensitivity to the diagnostic pharmaceuticals to be used in the study.
  • Is participating in any other type of clinical or research study.
  • Is a contact lens wearer.
  • Has blepharitis.

Key Trial Info

Start Date :

September 1 2007

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2007

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT00809003

Start Date

September 1 2007

End Date

December 1 2007

Last Update

December 16 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Centre for Contact Lens Research, School of Optometry

Waterloo, Ontario, Canada, N2L3G1